Berkeley Capital Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.08M Buy
12,608
+4,492
+55% +$1.05M 0.71% 23
2025
Q4
$1.68M Buy
8,116
+1,254
+18% +$248K 0.4% 49
2025
Q3
$1.27M Buy
6,862
+134
+2% +$23K 0.3% 70
2025
Q2
$1.03M Sell
6,728
-178
-3% -$27.4K 0.26% 81
2025
Q1
$1.15M Buy
6,906
+187
+3% +$29.3K 0.31% 70
2024
Q4
$972K Sell
6,719
-396
-6% -$61.4K 0.27% 78
2024
Q3
$1.15M Buy
7,115
+541
+8% +$86.2K 0.33% 67
2024
Q2
$961K Buy
6,574
+334
+5% +$49.7K 0.29% 70
2024
Q1
$987K Buy
6,240
+100
+2% +$15.9K 0.3% 69
2023
Q4
$962K Sell
6,140
-219
-3% -$33.6K 0.32% 66
2023
Q3
$990K Sell
6,359
-6,636
-51% -$1.09M 0.36% 58
2023
Q2
$2.15M Buy
12,995
+874
+7% +$141K 0.76% 22
2023
Q1
$1.88M Buy
12,121
+246
+2% +$39.7K 0.7% 23
2022
Q4
$2.1M Buy
11,875
+408
+4% +$70.4K 0.81% 22
2022
Q3
$1.87M Buy
11,467
+4,853
+73% +$821K 0.81% 19
2022
Q2
$1.17M Buy
6,614
+109
+2% +$19.4K 0.48% 36
2022
Q1
$1.15M Buy
6,505
+17
+0.3% +$2.89K 0.46% 35
2021
Q4
$1.11M Buy
6,488
+432
+7% +$70.7K 0.46% 31
2021
Q3
$978K Buy
6,056
+277
+5% +$47.3K 0.45% 33
2021
Q2
$952K Buy
5,779
+11
+0.2% +$1.82K 0.42% 34
2021
Q1
$948K Sell
5,768
-940
-14% -$152K 0.46% 30
2020
Q4
$1.06M Sell
6,708
-660
-9% -$97.4K 0.54% 27
2020
Q3
$1.1M Buy
7,368
+819
+13% +$121K 0.67% 22
2020
Q2
$921K Sell
6,549
-1,555
-19% -$227K 0.57% 27
2020
Q1
$1.06M Buy
8,104
+349
+5% +$49.5K 0.72% 21
2019
Q4
$1.13M Buy
7,755
+178
+2% +$24.1K 0.58% 35
2019
Q3
$980K Sell
7,577
-982
-11% -$129K 0.52% 40
2019
Q2
$1.19M Sell
8,559
-434
-5% -$60.1K 0.56% 31
2019
Q1
$1.26M Sell
8,993
-1,194
-12% -$160K 0.62% 28
2018
Q4
$1.31M Sell
10,187
-433
-4% -$60.4K 0.73% 23
2018
Q3
$1.47M Buy
10,620
+2,604
+32% +$346K 0.83% 21
2018
Q2
$972K Buy
8,016
+233
+3% +$29.1K 0.57% 40
2018
Q1
$997K Buy
7,783
+3,185
+69% +$430K 0.58% 39
2017
Q4
$642K Sell
4,598
-145
-3% -$20.2K 0.42% 62
2017
Q3
$617K Buy
4,743
+187
+4% +$24.8K 0.41% 71
2017
Q2
$603K Sell
4,556
-1,083
-19% -$138K 0.41% 59
2017
Q1
$702K Sell
5,639
-2,854
-34% -$341K 0.48% 55
2016
Q4
$979K Sell
8,493
-122
-1% -$14.1K 0.71% 32
2016
Q3
$1.02M Buy
8,615
+3,019
+54% +$366K 0.73% 28
2016
Q2
$679K Sell
5,596
-2,853
-34% -$324K 0.48% 47
2016
Q1
$914K Buy
8,449
+471
+6% +$48.8K 0.66% 33
2015
Q4
$820K Buy
+7,978
New +$802K 0.67% 34

Other funds holding JNJ

Berkeley Capital Partners's JNJ Position: Q1 2026 in Review

Berkeley Capital Partners increased its Johnson & Johnson (JNJ) stake by 55% in Q1 2026, buying an estimated $1.05M and bringing the position to 12,608 shares worth $3.08M. The position accounts for 0.71% of the portfolio, ranked #23.

Berkeley Capital Partners first reported a position in JNJ in Q4 2015 and has held it in 42 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Berkeley Capital Partners held 12,608 shares of Johnson & Johnson worth $3.08M as of Q1 2026.
  • Berkeley Capital Partners bought 4,492 Johnson & Johnson shares in Q1 2026, an estimated $1.05M.
  • Johnson & Johnson made up 0.71% of Berkeley Capital Partners's portfolio in Q1 2026, its #23 holding.
  • Berkeley Capital Partners first reported a position in Johnson & Johnson in Q4 2015 and has held it in 42 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Berkeley Capital Partners's 13F filing for Q1 2026, filed 7 May 2026.